We have now applied the enzyme immunoassay using anti-NGF monoclonal antibody (MAb) 27/21 and a blocking test validating the specificity of the immunoreactivity for NGF in serum samples to examine NGF levels in normal rat sera, hemiparkinsonian rat sera, normal monkey sera, and MPTP-treated monkey sera. The levels of NGF in treated animals showed reductions when compared with serum from normal animals. The NGF level alterations observed in lesioned animals and in human parkinsonian patients evidence a relationship between this neurotrophic factor and the neurodegenerative changes observed in Parkinson disease (PD).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF02815226 | DOI Listing |
Publication Analysis
Top Keywords
parkinson disease
8
rat sera
8
monkey sera
8
ngf
5
ngf experimental
4
experimental models
4
models parkinson
4
disease applied
4
applied enzyme
4
enzyme immunoassay
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!